Chapter 51 - INVESTIGATIONAL TREATMENTS
- Section 34-51-1 - Definitions
- Section 34-51-2 - Eligible patient defined
- Section 34-51-3 - Written, informed consent
- Section 34-51-4 - Treatment with investigational drug, biological product, or device
- Section 34-51-5 - Treatment without compensation permitted
- Section 34-51-6 - Reimbursement of manufacturer from decedent's estate prohibited
- Section 34-51-7 - Health care provider not liable for recommendation
- Section 34-51-8 - Treating physician immune
- Section 34-51-9 - State employees prohibited from blocking eligible patient's access to investigational drug, biological product, or device
- Section 34-51-10 - Private cause of action not authorized